Mechanistic understanding of HPK1 inhibition on enhanced human T cell activation and tumor immunity in a syngeneic model.

被引：0
|
作者：
Ciccone, David [1 ]
Lazari, Vad [2 ]
Linney, Ian [2 ]
Briggs, Michael [2 ]
Carreiro, Samantha [1 ]
Loh, Christine [1 ]
Tummino, Peter [1 ]
McElwee, Joshua [1 ]
Collis, Alan [1 ]
Kaila, Neelu [1 ]
机构：
[1] Nimbus Therapeut, Cambridge, MA USA
[2] Charles River Labs, Chesterford Res Pk, Saffron Walden, Essex, England
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1649
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Vasoactive intestinal peptide suppresses T cell activation via VPAC1 receptor and limits anti-tumor immunity
    Passang, Tenzin
    Wang, Shuhua
    Zhang, Hanwen
    Li, Jian-Ming
    Phillips, Maggie
    Karpovsky, Isaac
    Ravindranathan, Sruthi
    Waller, Edmund K.
    JOURNAL OF IMMUNOLOGY, 2024, 212 (01):
  • [42] T-cell activation through the inhibition of tumor-expressed IDO1 activity in tryptophan metabolism pathway
    Dong, Chunlan
    Wang, Ying
    Gong, Kefeng
    Xing, Frank
    Shi, Qian
    CANCER RESEARCH, 2018, 78 (13)
  • [43] Derazantinib, an FGFR1-3 inhibitor, inhibits CSF1R in macrophages and tumor cell lines, and synergizes with a PDL1-antibody in an FGFR-driven murine syngeneic model.
    El Shemerly, Mahmoud
    Kellenberger, Laurenz
    Zanini, Elisa
    Lane, Heidi
    McSheehy, Paul
    CANCER RESEARCH, 2022, 82 (12)
  • [44] Effect of short hairpin RNA targeting of fibroblast activation protein on tumor growth and angiogenesis in a 4T1 murine breast cancer model.
    Cai, Fan
    Peng, Feng
    Wang, Chunting
    Li, Zhiyong
    Xian, Shuang
    Wei, Yuquan
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [45] A small molecule human PD-1/PD-L1 inhibitor promotes T cell immune activation and reduces tumor growth in a preclinical model
    Colomer, M. Vilalta
    Punna, S.
    Li, S.
    Malathong, V.
    Lange, C.
    McMurtrie, D.
    Yang, J.
    Roth, H.
    McMahon, J.
    Campbell, J. J.
    Ertl, L. S.
    Ong, R.
    Wang, Y.
    Zhao, N.
    Yau, S.
    Dang, T.
    Zhang, P.
    Schall, T. J.
    Singh, R.
    ANNALS OF ONCOLOGY, 2018, 29
  • [46] Re: Simultaneous Inhibition of Two Regulatory T-Cell Subsets Enhanced Interleukin-15 Efficacy in a Prostate Tumor Model
    Atala, Anthony
    JOURNAL OF UROLOGY, 2013, 189 (02): : 770 - 770
  • [47] Agonist Anti-Human CD27 Monoclonal Antibody Induces T Cell Activation and Tumor Immunity in Human CD27-Transgenic Mice
    He, Li-Zhen
    Prostak, Naseem
    Thomas, Lawrence J.
    Vitale, Laura
    Weidlick, Jeffrey
    Crocker, Andrea
    Pilsmaker, Catherine D.
    Round, Sarah M.
    Tutt, Alison
    Glennie, Martin J.
    Marsh, Henry
    Keler, Tibor
    JOURNAL OF IMMUNOLOGY, 2013, 191 (08): : 4174 - 4183
  • [48] Inhibition of DCLK1 with DCLK1-IN-1 Suppresses Renal Cell Carcinoma Invasion and Stemness and Promotes Cytotoxic T-Cell-Mediated Anti-Tumor Immunity
    Ding, Ling
    Yang, Yuning
    Ge, Yang
    Lu, Qin
    Yan, Zixing
    Chen, Xuzheng
    Du, Jian
    Hafizi, Sassan
    Xu, Xiaohui
    Yao, Jiannan
    Liu, Jian
    Cao, Zhiyun
    Weygant, Nathaniel
    CANCERS, 2021, 13 (22)
  • [49] T cell receptor-dependent activation of human lymphocytes through cell surface ganglioside GT1b: implications for innate immunity
    Bukowski, JF
    Roncarolo, MG
    Spits, H
    Krangel, MS
    Morita, CT
    Brenner, MB
    Band, H
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2000, 30 (11) : 3199 - 3206
  • [50] TIPE2 is a novel direct target of STAT3 in MDSC and inhibition of its expression on MDSC enhanced T cell activation in tumor
    Yan, De Hong
    Wang, Jing Hui
    Wan, Xiao Chun
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
12345